tallózása szerző szerint "Kolho KL"

1-5 / 5

Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohn's Disease: Evaluation of the Porto IBD Group "Growth Relapse and Outcomes with Therapy" (GROWTH CD) Study.

Levine A; Turner D; Pfeffer Gik T; Amil Dias J; Veres, Gábor; Shaoul R; Staiano A; Escher J; Kolho KL; Paerregaard A; Martin de Carpi J; Veereman Wauters G; Koletzko S; Shevah O; Finnby L; Sladek M (2014)

BACKGROUND: Robust evaluation of induction therapies using both clinical and inflammatory outcomes in pediatric Crohn's disease (CD) are sparse. We attempted to evaluate clinical, inflammatory, and composite outcomes of ...
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents.

Levine A; Koletzko S; Turner D; Escher JC; Cucchiara S; de Ridder L; Kolho KL; Veres, Gábor; Russell RK; Paerregaard A; Buderus S; Greer ML; Dias JA; Veereman-Wauters G; Lionetti P; Sladek M; Carpi JM; Staiano A; Ruemmele FM; Wilson DC (2014)

BACKGROUND:: The diagnosis of pediatric-onset IBD (PIBD) can be challenging in choosing the most informative diagnostic tests and correctly classifying PIBD into its different subtypes. Recent advances in our understanding ...
Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's Disease

Shaoul R; Sladek M; Turner D; Paeregaard A; Veres, Gábor; Wauters GV; Escher J; Dias JA; Lionetti P; Staino A; Kolho KL; de Ridder L; Nuti F; Cucchiara S; Sheva O; Levine A; ESPGHAN Porto IBD Group (2012)

BACKGROUND: Fecal Calprotectin (FC) is a validated screening test for intestinal inflammation in Crohn's disease (CD). The objective of the study was to prospectively evaluate the limitations of FC for identifying CD in ...
Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group.

de Ridder L; Turner D; Wilson DC; Koletzko S; Martin-de-Carpi J; Fagerberg UL; Spray C; Sladek M; Shaoul R; Roma-Giannikou E; Bronsky J; Serban DE; Cucchiara S; Veres, Gábor; Ruemmele FM; Hojsak I; Kolho KL; Davies IH; Aloi M; Lionetti P; Veereman-Wauters G; Braegger CP; Trindade E; Wewer AV; Hauer A; Levine A (2014)

BACKGROUND: The combination of the severity of pediatric-onset inflammatory bowel disease (IBD) phenotypes and the need for intense medical treatment may increase the risk of malignancy and mortality, but evidence regarding ...
Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee.

Ruemmele FM; Hyams JS; Otley A; Griffiths A; Kolho KL; Dias JA; Levine A; Escher JC; Taminiau J; Veres, Gábor; Colombel JF; Vermeire S; Wilson DC; Turner D (2015)

OBJECTIVE: Although paediatric-onset IBD is becoming more common, few medications have a registered paediatric indication. There are multiple hurdles to performing clinical trials in children, emphasising the importance ...

1-5 / 5

Keresés

Összetett keresés

Tallózás

Teljes repozitórumban

Hozzáférésem

Bejelentkezés

tallózása szerző szerint "Kolho KL"

DSpace/Manakin Repository

tallózása szerző szerint "Kolho KL"

Keresés

Tallózás

Teljes repozitórumban

Hozzáférésem